Subtopic Deep Dive

C9orf72 Hexanucleotide Repeat Expansions
Research Guide

What is C9orf72 Hexanucleotide Repeat Expansions?

C9orf72 hexanucleotide repeat expansions refer to GGGGCC repeat amplifications in the C9orf72 gene that cause 40% of familial ALS/FTD cases through RNA foci, dipeptide repeat proteins via repeat-associated non-AUG translation, and nucleocytoplasmic transport defects.

These expansions produce toxic dipeptide repeats impairing membrane-less organelles and nuclear transport (Lee et al., 2016, 699 citations). Antisense transcripts form nuclear RNA foci and undergo RAN translation (Gendron et al., 2013, 572 citations). Over 150 papers document mechanisms and modifiers since discovery (Renton et al., 2013, 1512 citations).

15
Curated Papers
3
Key Challenges

Why It Matters

C9orf72 expansions drive 40% familial ALS cases, enabling RNA-targeted therapies like antisense oligonucleotides. Dipeptide repeats disrupt nucleocytoplasmic transport, linking to TDP-43 pathology and broad ALS/FTD mechanisms (Jovičić et al., 2015, 614 citations; Chou et al., 2018, 565 citations). Insights guide CRISPR editing and modifier screens, accelerating therapeutics (Balendra and Isaacs, 2018, 681 citations).

Key Research Challenges

Dipeptide Repeat Toxicity Mechanisms

GGGGCC repeats produce arginine-rich dipeptides via RAN translation that impair membrane-less organelles and nucleocytoplasmic transport (Lee et al., 2016, 699 citations). Toxicity connects to FTD/ALS via nuclear import defects (Jovičić et al., 2015, 614 citations). Dissecting selective neuronal vulnerability remains unresolved.

Nucleocytoplasmic Transport Defects

C9orf72 dipeptides and TDP-43 aggregates disrupt nuclear pore complexes, blocking protein localization (Chou et al., 2018, 565 citations; Garcia-Bustos et al., 1991, 554 citations). Modifiers link these defects to disease progression (Jovičić et al., 2015, 614 citations). Quantifying transport kinetics in patient models is challenging.

Therapeutic Targeting of Repeats

Antisense oligonucleotides and CRISPR strategies target expanded repeats, but off-target effects and repeat instability complicate delivery (Mejzini et al., 2019, 729 citations). RAN translation from antisense strands adds toxicity layers (Gendron et al., 2013, 572 citations). Clinical translation lags due to somatic instability.

Essential Papers

1.

State of play in amyotrophic lateral sclerosis genetics

Alan E. Renton, Adriano Chiò, Bryan J. Traynor · 2013 · Nature Neuroscience · 1.5K citations

2.

Hallmarks of neurodegenerative diseases

David M. Wilson, Mark Cookson, Ludo Van Den Bosch et al. · 2023 · Cell · 1.4K citations

3.

ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now?

Rita Mejzini, Loren L. Flynn, Ianthe Pitout et al. · 2019 · Frontiers in Neuroscience · 729 citations

The scientific landscape surrounding amyotrophic lateral sclerosis (ALS) continues to shift as the number of genes associated with the disease risk and pathogenesis, and the cellular processes invo...

4.

C9orf72 Dipeptide Repeats Impair the Assembly, Dynamics, and Function of Membrane-Less Organelles

Kyung‐Ha Lee, Peipei Zhang, Hong Joo Kim et al. · 2016 · Cell · 699 citations

5.

C9orf72-mediated ALS and FTD: multiple pathways to disease

Rubika Balendra, Adrian M. Isaacs · 2018 · Nature Reviews Neurology · 681 citations

6.

Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALS

Ana Jovičić, Jérôme Mertens, Steven Boeynaems et al. · 2015 · Nature Neuroscience · 614 citations

7.

Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD/ALS

Tania F. Gendron, Kevin F. Bieniek, Yong‐Jie Zhang et al. · 2013 · Acta Neuropathologica · 572 citations

Frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) are devastating neurodegenerative disorders with clinical, genetic, and neuropathological overlap. A hexanucleotide (GGGGCC) re...

Reading Guide

Foundational Papers

Start with Renton et al. (2013, 1512 citations) for genetic discovery; Gendron et al. (2013, 572 citations) for RAN/RNA foci; Blokhuis et al. (2013, 560 citations) for aggregation context.

Recent Advances

Lee et al. (2016, 699 citations) on dipeptide organelle effects; Balendra & Isaacs (2018, 681 citations) on pathways; Chou et al. (2018, 565 citations) on TDP-43 transport links.

Core Methods

RAN translation via polysome profiling; nuclear import assays with reporters; dipeptide aggregation by FRAP; modifier screens in yeast/Drosophila (Jovičić et al., 2015).

How PapersFlow Helps You Research C9orf72 Hexanucleotide Repeat Expansions

Discover & Search

Research Agent uses citationGraph on Renton et al. (2013, 1512 citations) to map C9orf72 genetics clusters, then exaSearch for 'C9orf72 dipeptide nucleocytoplasmic transport' yielding 200+ papers like Jovičić et al. (2015). findSimilarPapers on Lee et al. (2016) uncovers dipeptide organelle studies.

Analyze & Verify

Analysis Agent runs readPaperContent on Gendron et al. (2013) to extract RAN translation data, then verifyResponse with CoVe against Chou et al. (2018) for transport claims. runPythonAnalysis quantifies repeat lengths from figures using pandas, with GRADE scoring evidence strength for toxicity pathways.

Synthesize & Write

Synthesis Agent detects gaps in nucleocytoplasmic modifier studies via contradiction flagging across Jovičić et al. (2015) and Balendra & Isaacs (2018). Writing Agent applies latexEditText to draft repeat toxicity reviews, latexSyncCitations for 50+ refs, and latexCompile for camera-ready manuscripts; exportMermaid diagrams RAN translation pathways.

Use Cases

"Quantify dipeptide repeat lengths and toxicity correlations from C9orf72 ALS papers"

Research Agent → searchPapers('C9orf72 dipeptide lengths') → Analysis Agent → readPaperContent(Lee et al. 2016) + runPythonAnalysis(pandas image extraction, matplotlib correlation plots) → CSV export of 100+ repeat metrics.

"Draft LaTeX review on C9orf72 RAN translation mechanisms"

Synthesis Agent → gap detection(Gendron et al. 2013 + Wen et al. 2014) → Writing Agent → latexEditText(structured sections) → latexSyncCitations(20 papers) → latexCompile(PDF) → peer-ready manuscript with diagrams.

"Find code for modeling C9orf72 repeat expansions"

Research Agent → paperExtractUrls(Lee et al. 2016) → Code Discovery → paperFindGithubRepo → githubRepoInspect(Numpy simulations) → runPythonAnalysis(reproduce dipeptide dynamics).

Automated Workflows

Deep Research workflow scans 50+ C9orf72 papers via searchPapers → citationGraph → structured report on repeat toxicity evolution (Renton et al. 2013 baseline). DeepScan applies 7-step CoVe to verify transport claims across Jovičić et al. (2015) and Chou et al. (2018), with GRADE checkpoints. Theorizer generates hypotheses linking dipeptide modifiers to TDP-43 aggregation.

Frequently Asked Questions

What defines C9orf72 hexanucleotide repeat expansions?

GGGGCC repeats >30 in C9orf72 intron 1 cause 40% familial ALS/FTD via RNA foci, RAN dipeptides, and transport defects (Renton et al., 2013).

What are main methods studying these expansions?

RAN translation assays detect dipeptides; FISH visualizes RNA foci; NPC disruption measured by nuclear import reporters (Gendron et al., 2013; Jovičić et al., 2015).

What are key papers?

Renton et al. (2013, 1512 citations) on genetics; Lee et al. (2016, 699 citations) on organelle disruption; Gendron et al. (2013, 572 citations) on RAN translation.

What open problems exist?

Somatic repeat instability, selective toxicity mechanisms, and scalable CRISPR/ASO delivery for unstable repeats (Mejzini et al., 2019).

Research Amyotrophic Lateral Sclerosis Research with AI

PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:

See how researchers in Health & Medicine use PapersFlow

Field-specific workflows, example queries, and use cases.

Health & Medicine Guide

Start Researching C9orf72 Hexanucleotide Repeat Expansions with AI

Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.

See how PapersFlow works for Medicine researchers